VPHM Insider Trading Activity and SEC Form 4 Filings
VPHM insider trading summary
No open-market insider purchases or sales of Viropharma Inc (VPHM) have been reported on SEC Form 4 in the past 12 months.
Latest VPHM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 24, 2012 | Colin MD Broom | VP & Chief Scientific Officer | Sell | $394K (17,500 @ $22.53) |
| Dec 13, 2012 | Paul A Brooke | Director | Sell | $1.4M (60,000 @ $23.87) |
| Dec 10, 2012 | Colin MD Broom | VP & Chief Scientific Officer | Sell | $361K (14,999 @ $24.07) |
| Dec 10, 2012 | Colin MD Broom | VP & Chief Scientific Officer | Sell | $1.2M (50,000 @ $24.07) |
| Dec 10, 2012 | Colin MD Broom | VP & Chief Scientific Officer | Sell | $241K (10,000 @ $24.07) |
| Dec 3, 2012 | John Peter Wolf III | VP, General Counsel | Sell | $447K (18,000 @ $24.85) |
| Dec 3, 2012 | William D Md Claypool | Director | Sell | $248K (10,000 @ $24.80) |
| Dec 3, 2012 | Michael R Dougherty | Director | Buy | $63K (2,500 @ $25.07) |
| Nov 30, 2012 | Robert Glaser | Director | Sell | $248K (10,000 @ $24.78) |
| Nov 30, 2012 | Robert Glaser | Director | Sell | $496K (20,000 @ $24.78) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.